Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Pharmaceutical Technology

23:25 EDT 20th October 2018 | BioPortfolio

Here are the most relevant search results for "Pharmaceutical Technology" found in our extensive news archives from over 250 global news sources.

More Information about Pharmaceutical Technology on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Pharmaceutical Technology for you to read. Along with our medical data and news we also list Pharmaceutical Technology Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pharmaceutical Technology Companies for you to search.

Showing News Articles 1–25 of 1,000+ from Pharmaceutical Technology

Friday 19th October 2018

Ipsen seeks candidates as it looks to spend over €1bn on pipeline growth

Ipsen is actively scouting candidates to boost its oncology, rare disease and neuroscience portfolio, said chief business officer Ivana Magovčević-Liebisch. The...Read More... The post Ipsen seeks candidates as it looks to spend over €1bn on pipeline growth appeared first on Pharmaceutical Technology.

Pace of cancer drug reimbursement varies wildly across Europe

Researchers have found that some European countries take more than twice as long as others to reach health technology assessment...Read More... The post Pace of cancer drug reimbursement varies wildly across Europe appeared first on Pharmaceutical Technology.

Thursday 18th October 2018

ACCC’s appeal over Pfizer Australia ruling on Lipitor dismissed

The Australian high court has dismissed the Australian Competition and Consumer Commission’s (ACCC) application for special leave to appeal the...Read More... The post ACCC’s appeal over Pfizer Australia ruling on Lipitor dismissed appeared first on Pharmaceutical Technology.

Deals this week: Eisai Pharmaceutical, Abbvie, Otsuka

Eisai Pharmaceutical has signed an agreement with Eurofarma Laboratorios for the marketing and distribution of its anti-obesity drug lorcaserin hydrochloride...Read More... The post Deals this week: Eisai Pharmaceutical, Abbvie, Otsuka appeared first on Pharmaceutical Technology.

Deals this week: Emergent BioSolutions, Pediapharm, Adynxx

Emergent BioSolutions has acquired Adapt Pharma in a deal valued at up to $735m. Adapt Pharma will receive an upfront...Read More... The post Deals this week: Emergent BioSolutions, Pediapharm, Adynxx appeared first on Pharmaceutical Technology.

Novartis to acquire US cancer drug developer Endocyte for $2.1bn

Swiss pharmaceutical firm Novartis has signed a $2.1bn deal to purchase all outstanding shares of US-based biopharmaceutical company Endocyte in...Read More... The post Novartis to acquire US cancer drug developer Endocyte for $2.1bn appeared first on Pharmaceutical Technology.

Takeda gets Japanese approval for $62bn Shire acquisition

Takeda Pharmaceutical is close to completing the $62bn acquisition of Irish biopharmaceutical company Shire after receiving approval from the Japan...Read More... The post Takeda gets Japanese approval for $62bn Shire acquisition appeared first on Pharmaceutical Technology.

NeuroActiva looks to raise up to $200m by mid-2019 for Alzheimer’s trial

NeuroActiva is actively discussing either a large pharma partnership or a potential NASDAQ public listing (IPO) by mid-2019 to raise...Read More... The post NeuroActiva looks to raise up to $200m by mid-2019 for Alzheimer’s trial appeared first on Pharmaceutical Technology.

Lantern Project: Genzyme and PerkinElmer highlight lysosomal storage disorders

For a disease group that cannot yet be cured, the administrations of therapies that slow the progression of the disease...Read More... The post Lantern Project: Genzyme and PerkinElmer highlight lysosomal storage disorders appeared first on Pharmaceutical Technology.

Wednesday 17th October 2018

Changsheng Bio-Technology fined $1.3bn after vaccine scandals

A Chinese drug watchdog has imposed a fine and asset seizure worth CNY9.1bn ($1.3bn) on Changsheng Bio-Technology following two major...Read More... The post Changsheng Bio-Technology fined $1.3bn after vaccine scandals appeared first on Pharmaceutical Technology.

Sanofi’s Dupixent meets Phase III trial endpoints for rhinosinusitis

Sanofi has reported positive results from two Phase III clinical trials for its Dupixent drug in adults with inadequately controlled...Read More... The post Sanofi’s Dupixent meets Phase III trial endpoints for rhinosinusitis appeared first on Pharmaceutical Technology.

AZ’s Brexit freeze will be short-term, but UK pharma’s future remains unclear

AstraZeneca announced this week that it would be freezing investment in its UK operations until greater clarity was provided over...Read More... The post AZ’s Brexit freeze will be short-term, but UK pharma’s future remains unclear appeared first on Pharmaceutical Technology.

Europe’s updated guidelines on atopic dermatitis

The latest update to the consensus-based European guidelines for the treatment of atopic dermatitis in adults and children was published...Read More... The post Europe’s updated guidelines on atopic dermatitis appeared first on Pharmaceutical Technology.

How will the UK’s relaxed cannabis regulations impact clinical practice?

The UK home secretary announced that as of November 1, specialist doctors will be given the option to legally prescribe...Read More... The post How will the UK’s relaxed cannabis regulations impact clinical practice? appeared first on Pharmaceutical Technology.

Samsung Bioepis’ biosimilar to Humira launched in the EU

Samsung Bioepis has announced the launch of its Imraldi, an adalimumab biosimilar to Humira, in the European Union (EU); the...Read More... The post Samsung Bioepis’ biosimilar to Humira launched in the EU appeared first on Pharmaceutical Technology.

Verge Genomics: employing AI to improve drug discovery

Artificial Intelligence (AI) and machine learning has begun to dominate innovation in the medical field with the help of an...Read More... The post Verge Genomics: employing AI to improve drug discovery appeared first on Pharmaceutical Technology.

Tuesday 16th October 2018

SQZ Biotech signs up to $1bn immuno-oncology deal with Roche

Cell therapy company SQZ Biotechnologies has expanded its deal worth up to $1bn with Roche for the development and commercialisation...Read More... The post SQZ Biotech signs up to $1bn immuno-oncology deal with Roche appeared first on Pharmaceutical Technology.

Samsung BioLogics may face legal action for alleged accounting breach

South Korea-based biopharmaceutical company Samsung BioLogics is likely to face disciplinary measures due to an alleged accounting breach. The country’s...Read More... The post Samsung BioLogics may face legal action for alleged accounting breach appeared first on Pharmaceutical Technology.

Roche reports sales growth as new drugs ease pressure from biosimilar competition

Swiss pharma company Roche reported 7% year on year increase in sales to CHF42.1bn ($42.5bn) in the first nine months...Read More... The post Roche reports sales growth as new drugs ease pressure from biosimilar competition appeared first on Pharmaceutical Technology.

Trial design should give Dermira’s AD drug a better shot at Phase IIb success

Dermira’s lebrikizumab Phase IIb trial for atopic dermatitis (AD) has a better shot at statistical and clinical significance with the exclusion...Read More... The post Trial design should give Dermira’s AD drug a better shot at Phase IIb success appeared first on Pharmaceutical Technology.

AstraZeneca to continue UK investment freeze due to Brexit uncertainty

Anglo-Swedish biopharma company AstraZeneca’s non-executive chairman Leif Johansson has unveiled to French newspaper La Monde that the company will continue...Read More... The post AstraZeneca to continue UK investment freeze due to Brexit uncertainty appeared first on Pharmaceutical Technology.

AstraZeneca to continue investment freeze in UK due to Brexit uncertainty

Anglo-Swedish biopharma company AstraZeneca’s non-executive chairman Leif Johansson has unveiled to French newspaper La Monde that the company will continue...Read More... The post AstraZeneca to continue investment freeze in UK due to Brexit uncertainty appeared first on Pharmaceutical Technology.

Roche’s Hemlibra: a (Bi)-specific shift in the hemophilia A market

The hemophilia drug market is currently undergoing major changes due to advances in recombinant protein engineering, as well as the...Read More... The post Roche’s Hemlibra: a (Bi)-specific shift in the hemophilia A market appeared first on Pharmaceutical Technology.

Monday 15th October 2018

Immugenyx and Janssen to develop SLE model for drug development

Immugenyx has signed a collaboration agreement with Janssen Research & Development to develop an in-vivo platform that will aid in...Read More... The post Immugenyx and Janssen to develop SLE model for drug development appeared first on Pharmaceutical Technology.

US FDA grants ODD to Lynparza for treatment of pancreatic cancer

The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for Lynparza (olaparib) to be used for the...Read More... The post US FDA grants ODD to Lynparza for treatment of pancreatic cancer appeared first on Pharmaceutical Technology.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks